Clinical Trials · NCT06582446

Artificial Intelligence to Personalize Prostate Cancer Treatment (the HypoElect Trial)

Phase
Phase 2
Recruitment status
Recruiting
Sponsor
German Oncology Center, Cyprus
Enrollment
30
Start date
Sep 2024
Locations
1 site, Cyprus
Primary endpoint
cumulative GU toxicity
View Gonadorelin compound reference